Back to mobile site

Leerink Upgrades Summit Therapeutics plc (SMMT) to Market Perform

August 12, 2026 6:34 AM EDT Send to a Friend
Leerink analyst Daina Graybosch upgraded Summit Therapeutics plc (NASDAQ: SMMT) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login